Medical News

RSS

Promising preliminary results for AKB-9778 in diabetic macular oedema

AKB-9778, a small molecule competitive inhibitor of vascular endothelial-protein tyrosine phosphatase, has a good safety and efficacy profile in patients with diabetic macular oedema, suggests a preliminary dose-escalation study.

19 May 2015

Similar diabetic macular oedema outcomes with deferred vs prompt laser therapy

Visual acuity outcomes are comparable in diabetic macular oedema patients who receive laser treatment 24 weeks or more after initiation of ranibizumab injections and those for whom laser therapy is initiated concurrently, show the 5-year results of a US study.

19 May 2015

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Researchers have found three factors that could identify which patients with retinal angiomatous proliferation receiving anti-vascular endothelial growth factor treatment are likely to develop geographic atrophy.

19 May 2015

hESC-derived cells offer source of macular tissue repair and replacement

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt’s macular dystrophy, suggest two open-label phase I/II studies.

19 May 2015

Women born preterm have higher risk of preterm delivery, study finds

Women who were born preterm have a higher risk of giving birth to preterm children, according to a study, published in the journal Obstetrics & Gynecology, from researchers of the CHU Sainte-Justine and the University of Montreal.

19 May 2015

Study finds that nearly 35% of U.S. adults have metabolic syndrome

Nearly 35 percent of all U.S. adults and 50 percent of those 60 years of age or older were estimated to have the metabolic syndrome in 2011-2012, according to a study in the May 19 issue of JAMA.

19 May 2015

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

A new study by UCLA researchers has found that Naltrexone, a drug used to treat alcoholism, may also be a promising treatment for addiction to methamphetamine.

19 May 2015

CWRU's Frances Payne Bolton School of Nursing receives grant to study multiple chronic conditions

Case Western Reserve University's Frances Payne Bolton School of Nursing will begin training predoctoral and postdoctoral researchers to study people with multiple chronic illnesses in hopes of discovering better methods for managing such a complex combination of illnesses.

19 May 2015

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.

19 May 2015

DWHP announces sale of Health & Safety Institute to Riverside

DW Healthcare Partners, a healthcare-focused private equity, announced the sale of its portfolio company, Health & Safety Institute, Inc., to The Riverside Company, a New York-based private equity firm. The terms of the transaction were not disclosed.

19 May 2015

Scientists working together to help parents motivate children to increase calcium intake

Scientists from 11 land-grant institutions and Brigham Young University are working together to help parents motivate children to boost calcium intake to strengthen bones and prevent bone fractures from occurring later in life.

19 May 2015

MedVantx launches MedStart Formulary Connect program for health systems and ACOs

MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.

19 May 2015

CLDF collaborates with Walgreens to offer free rapid HCV testing

The Chronic Liver Disease Foundation announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick HCV Rapid Test at more than 60 Walgreens retail pharmacies in 12 major cities throughout the country.

19 May 2015

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).

19 May 2015

Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Verde Technologies announced that Golden Valley-based Twin Cities Orthopedics, the largest orthopedic group in Minnesota, has become its most recent partner in the fight against prescription drug abuse and misuse.

19 May 2015

Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Among patients with acute sciatica caused by a herniated lumbar disk (a condition also known as "acute radiculopathy"), a short course of oral steroids resulted in only modest improvement in function and no significant improvement in pain, according to a study published today in the Journal of the American Medical Association.

19 May 2015

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.

19 May 2015

Medical News

Promising preliminary results for AKB-9778 in diabetic macular oedema

Similar diabetic macular oedema outcomes with deferred vs prompt laser therapy

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

hESC-derived cells offer source of macular tissue repair and replacement

Women born preterm have higher risk of preterm delivery, study finds

Study finds that nearly 35% of U.S. adults have metabolic syndrome

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

CWRU's Frances Payne Bolton School of Nursing receives grant to study multiple chronic conditions

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

DWHP announces sale of Health & Safety Institute to Riverside

Scientists working together to help parents motivate children to increase calcium intake

MedVantx launches MedStart Formulary Connect program for health systems and ACOs

CLDF collaborates with Walgreens to offer free rapid HCV testing

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

California PACE enrollment continues to rise

Exact Imaging's ExactVu micro-ultrasound platform introduced at AUA 2015 Annual Meeting

OrthoSpace announces completion of financing transaction

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News